View drug registration information details.
| Items | Registration information |
|---|
| ID | 2842 |
|---|
| No | 2842 |
|---|
| Brand Name | GLIPITA M 50 /1000 |
|---|
| Ingredients | SITAGLIPTIN PHOSPHATE MONOHYDRATE BP 64.250 MG EQ. TO SITAGLIPTIN 50 MG, METFORMIN HYDROCHLORIDE BP 1000 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | ALU-PVDC BLISTER |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 3 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | AS AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIA CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | AN ORANGE COLORED, OBLONG SHAPED CORE TABLET ENGRAVED BPL ON ONE SIDE AND PLAIN ON THE OTHER |
|---|
| Note | |
|---|
| License Owner | VIMPEX (LAO) CO.,LTD |
|---|
| Manufacturer | BEXIMCO PHARMACEUTICALS LTD |
|---|
| Country | BANGLADESH |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 10 I 4613/18 |
|---|
| FDD Registration Date | 08-JAN-2024 |
|---|
| Expiry Date | 07-JAN-2027 |
|---|
Back to drug list
|
